Co-Diagnostics Inc
(CODX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,444 | 11,115 | 1,903 | 2,937 | 10,798 |
| Marketable Securities | N/A | 2,248 | 19,576 | 26,811 | 26,865 |
| Receivables | 979 | 211 | 136 | 133 | 178 |
| Inventories | 1,090 | 1,085 | 1,083 | 1,073 | 1,266 |
| TOTAL | $14,055 | $15,307 | $23,832 | $32,292 | $40,103 |
| Non-Current Assets | |||||
| PPE Net | 2,485 | 2,673 | 2,594 | 2,761 | 2,984 |
| Investments And Advances | 660 | 716 | 730 | 731 | 784 |
| Intangibles | 26,101 | 26,101 | 26,101 | 26,101 | 26,177 |
| Other Non-Current Assets | 1,440 | 1,668 | 1,894 | 2,115 | 2,333 |
| TOTAL | $30,686 | $31,159 | $31,318 | $31,708 | $32,278 |
| Total Assets | $44,741 | $46,466 | $55,149 | $64,000 | $72,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,458 | 1,635 | 2,713 | 3,294 | 2,176 |
| Accrued Expenses | 1,205 | 1,008 | 1,611 | 2,562 | 1,826 |
| Other current liabilities | 240 | 198 | 109 | 503 | 838 |
| TOTAL | $3,693 | $3,711 | $5,377 | $7,316 | $5,798 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 46 | 46 | 41 | 41 | 61 |
| Other Non-Current Liabilities | 728 | 879 | 1,127 | 1,659 | 2,080 |
| TOTAL | $1,220 | $1,616 | $1,852 | $2,372 | $2,799 |
| Total Liabilities | $4,913 | $5,327 | $7,229 | $9,688 | $8,597 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,028 | 1,283 | 1,123 | 1,118 | 1,063 |
| Common Shares | 53 | 41 | 38 | 38 | 37 |
| Retained earnings | -54,191 | -48,304 | -40,574 | -33,041 | -22,010 |
| Other shareholders' equity | 519 | 558 | 755 | 843 | 833 |
| TOTAL | $39,828 | $41,138 | $47,921 | $54,312 | $63,784 |
| Total Liabilities And Equity | $44,741 | $46,466 | $55,149 | $64,000 | $72,381 |